StemSight

Private

TampereHealthcare & Life Scienceshttps://www.stemsight.fi/

Last Round

Seed

Feb 11, 2025

Total Funding Raised

$1.89M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

StemSight is a biotechnology company developing off-the-shelf cell therapies based on induced pluripotent stem cells (iPSCs) to treat corneal blindness.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Advanced Materials, 3D Printing

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

regenerative cell therapyoff-the-shelf cell therapyiPSCsinduced pluripotent stem cellsLSCDLimbal Stem Cell Deficiencycorneal blindnessstem cell therapyregenerative medicineallogeneic cell therapybiomaterialscorneal regenerationophthalmologypreclinical biotechbioprintingcorneal endothelial cells

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

StemSight Comps

Public and private peers based on sector, stage, and business model.

StemSight comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

StemSight Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Feb 11, 2025
Pre Seed	Aug 31, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Heli Skottman

Co-Founder And CTO

Founding Team

Laura Koivusalo

CEO And Founder

Founding Team

Samantha Macro

CFO

Executive Team

StemSight Investors

Notable investors and investment history

StemSight investors
Investor	Rounds
Business Finland	Seed
Biothom Oy	Seed
European Regional Development Fund (ERDF)	Grant
Voima Ventures	Pre Seed, Seed
Avohoidon Tutkimussäätiö	Pre Seed
Stephen Industries Inc Oy	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 18, 2026
Monthly visitors increased 891% MoM.
Jan 6, 2026
Monthly visitors grew 258% MoM, reaching 974.

View all signals

StemSight Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

StemSight Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about StemSight's valuation, stock price, and market status.

Firmographic Details

HeadquartersTampere

Employee Range19

Year Founded2021

Last FundingFeb 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.